<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56"><gtr:id>DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56</gtr:id><gtr:name>School of Clinical Medicine</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Pathology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56"><gtr:id>DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56</gtr:id><gtr:name>School of Clinical Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/FF82D960-A795-47FC-AF52-4432806D2D98"><gtr:id>FF82D960-A795-47FC-AF52-4432806D2D98</gtr:id><gtr:firstName>Colin</gtr:firstName><gtr:surname>Crump</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0700129"><gtr:id>E758AE26-70E6-4090-9919-2D65AD7FDC64</gtr:id><gtr:title>The role of endosomal sorting proteins in HSV-1 assembly</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700129</gtr:grantReference><gtr:abstractText>The herpesviruses are an important group of pathogens that infect humans and cause several medical problems including cold sores, shingles and glandular fever. Herpesviruses can also increase the risk of certain types of cancer, and can cause life-threatening conditions in immune-suppressed people, such as transplant patients. To be able to treat and control infections by these viruses, it is crucial that we understanding how these viruses infect us, how they produce new copies of themselves, and how they spread to new people. The research being proposed will use cell culture models to study the way in which herpesviruses control our cells own machinery in order to form new copies of the virus. Overall, the information gained from this research will give a greater understanding of how this important family of viruses can infect and replicate in our cells. Such information will hopefully identify new targets that could be inhibited by drugs to combat these viruses and the many diseases caused by them.</gtr:abstractText><gtr:technicalSummary>Herpesviruses are large, complex DNA viruses that are ubiquitous pathogens of vertebrates. Infections by the eight known human herpesviruses are associated with many serious diseases, including certain lymphomas and life-threatening conditions in immune-suppressed patients. Crucial to our ability to treat and control herpesvirus infection and spread is the understanding of the biology behind viral assembly and egress. 

Herpesviruses acquire their final envelope, containing several viral glycoproteins, by the budding of cytoplasmic nucleocapsids across membranes derived from either the trans-Golgi network or endosomes. We now have convincing preliminary evidence that the multivesicular endosome (MVE) sorting machinery is required for this cytoplasmic envelopment of HSV-1, although how this machinery is utilised and regulated by this virus is unknown. This research will be an in depth analysis of the role of the cellular MVE machinery in HSV-1 assembly. Key goals will be demonstrating which components of the multi-protein MVE sorting complexes are necessary and sufficient for HSV-1 envelopment; investigation of the recruitment of MVE machinery to HSV-1 assembly sites; analyses of potentially novel interactions between MVE and viral proteins; and the role of ubiquitin in HSV-1 assembly.</gtr:technicalSummary><gtr:fund><gtr:end>2011-02-28</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>390999</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Molecular and Cellular Biology</gtr:department><gtr:description>Investigation of the role of ESCRTs in hepatitis C virus release</gtr:description><gtr:id>676FD472-71DB-4829-83C7-55582A5A7E45</gtr:id><gtr:impact>Publication, PMID: 19828764</gtr:impact><gtr:partnerContribution>Extended our knowledge on the role of ESCRTs in virus release - hepatitis C virus</gtr:partnerContribution><gtr:piContribution>Reagents and expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Clinical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>Investigation of the role of ESCRTs in influenza virus budding</gtr:description><gtr:id>9215AE50-31DA-4B60-A4FA-76F4441B9625</gtr:id><gtr:impact>Publication, PMID: 19524996</gtr:impact><gtr:partnerContribution>Extended our knowledge on the role of ESCRTs in virus budding - influenza virus</gtr:partnerContribution><gtr:piContribution>Reagents, expertise and some experimental work for this research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>International Herpesvirus Workshop Phase I Travel Support Award (For PhD student from my laboratory)/International Herpesvirus Workshop 2011</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>International Herpesvirus Workshop</gtr:fundingOrg><gtr:id>E7089BA9-EC5F-4AFA-A7D8-0498D2EF7AA4</gtr:id><gtr:sector>Multiple</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25520</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Isaac Newton Trust</gtr:department><gtr:description>Isaac Newton Trust Research Grant</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:fundingRef>11.06(aa)</gtr:fundingRef><gtr:id>B7010E9D-5CF5-4119-BD25-78AD60AC1D79</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>International Herpesvirus Workshop Phase I Travel Support Award (For PhD student from my laboratory)/International Herpesvirus Workshop 2010</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>International Herpesvirus Workshop</gtr:fundingOrg><gtr:id>9A65BDDF-3435-4704-BD49-C6218DAFB652</gtr:id><gtr:sector>Multiple</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>310285</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University Research Fellowship (Renewal)</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:fundingRef>UF090010</gtr:fundingRef><gtr:id>050DB298-7467-4BA0-84AA-F16602AB515D</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Novel mouse monoclonal antibodies that are specific to the herpes simplex virus tegument proteins pUL36, pUL37 and envelope proteins gM and gB.</gtr:description><gtr:id>CA19A388-F8D6-443E-A6CF-557AAF6A720F</gtr:id><gtr:impact>Very few antibodies to pUL36, pUL37 and gM currently exist in the world and the antibodies we have generated have proved to be very useful reagents for the investigation of the subcellular localisation of these viral proteins in infected cells. Data using these some of these new antibodies will soon be prepared for publication.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Monoclonal antibodies to HSV proteins</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8796C68B-0956-4A2E-9916-8D10490DFA5A"><gtr:id>8796C68B-0956-4A2E-9916-8D10490DFA5A</gtr:id><gtr:title>Budding of filamentous and non-filamentous influenza A virus occurs via a VPS4 and VPS28-independent pathway.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12166224984715583d7220bc66bd7d48"><gtr:id>12166224984715583d7220bc66bd7d48</gtr:id><gtr:otherNames>Bruce EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C68A2E54-A3C5-40A2-8691-0AC140FA89A2"><gtr:id>C68A2E54-A3C5-40A2-8691-0AC140FA89A2</gtr:id><gtr:title>Analysis of the interaction between the essential herpes simplex virus 1 tegument proteins VP16 and VP1/2.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a84c4cd091e8d6e777ec00e64a501629"><gtr:id>a84c4cd091e8d6e777ec00e64a501629</gtr:id><gtr:otherNames>Svobodova S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52EC77CA-22F0-49EA-A275-7551CCE47939"><gtr:id>52EC77CA-22F0-49EA-A275-7551CCE47939</gtr:id><gtr:title>Analysis of Rab GTPase-activating proteins indicates that Rab1a/b and Rab43 are important for herpes simplex virus 1 secondary envelopment.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/62ab9995e58650c8789d10b09f0cffd0"><gtr:id>62ab9995e58650c8789d10b09f0cffd0</gtr:id><gtr:otherNames>Zenner HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/09D77BA8-48AF-41EE-99A6-195029112BF8"><gtr:id>09D77BA8-48AF-41EE-99A6-195029112BF8</gtr:id><gtr:title>Herpes simplex virus 1 counteracts tetherin restriction via its virion host shutoff activity.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/62ab9995e58650c8789d10b09f0cffd0"><gtr:id>62ab9995e58650c8789d10b09f0cffd0</gtr:id><gtr:otherNames>Zenner HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A7D70230-EB65-4EEA-80E1-DC85FAADC554"><gtr:id>A7D70230-EB65-4EEA-80E1-DC85FAADC554</gtr:id><gtr:title>Herpes simplex virus type 1 production requires a functional ESCRT-III complex but is independent of TSG101 and ALIX expression.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f46d7f6ddf72a38194f61ab006329e82"><gtr:id>f46d7f6ddf72a38194f61ab006329e82</gtr:id><gtr:otherNames>Pawliczek T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/94538466-FBAC-41F3-BBBF-979E5457036C"><gtr:id>94538466-FBAC-41F3-BBBF-979E5457036C</gtr:id><gtr:title>Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/069f71bcd262740affe2024bce8eb446"><gtr:id>069f71bcd262740affe2024bce8eb446</gtr:id><gtr:otherNames>Corless L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A155FCAE-F75E-4337-8839-CB42BFCC16BB"><gtr:id>A155FCAE-F75E-4337-8839-CB42BFCC16BB</gtr:id><gtr:title>Glycoprotein M is important for the efficient incorporation of glycoprotein H-L into herpes simplex virus type 1 particles.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/261db89689335d264226fc6ed877ed5d"><gtr:id>261db89689335d264226fc6ed877ed5d</gtr:id><gtr:otherNames>Ren Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700129</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>